Policy

• 

  Policy Matters

  Racial and Ethnic Disparities in Multiple Myeloma Clinical Trials

  The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

  by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

• 

  Survivor Profile

  Sharing Her Strength

  Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

  by Lindsey Konkel

• 

  Robotic Surgery and Cancer

  Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

  by Sue Rochman

• 

  Pushing Progress Forward

  NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”

  by Kevin McLaughlin

• 

  Cancer Care Moves Forward Amid COVID-19

  Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.

  by Kate Yandell

• 

  Using Leftover Cancer Drugs to Help Others

  Cancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.

  by Jon Kelvey

• 

  Forward Look

  Makers of E-Cigarettes Tout Role in Smoking Cessation

  Studies provide little evidence to support this claim.

  by Stephen Ornes

• 

  Policy Matters

  Taking Steps to Address Cancer Health Disparities

  Cancer outcomes are changing for the better, but advances are not affecting all patients equally.

  by Brian Rivers, PhD

• 

  The Coronavirus Impacts Cancer Clinical Trials

  The National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.

  by Anna Azvolinsky

• 

  Medicare Coverage for Next-Generation Sequencing Tests

  Multigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.

  by Ashley P. Taylor